Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $260 to $210.
Mizuho Maintains Buy on HCA Healthcare, Lowers Price Target to $210
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Buy and lowers the price target from $260 to $210.
Related Posts
Why AMC Networks Shares Are Shooting Higher Today
AMC Networks Inc (NASDAQ:AMCX) reported first-quarter revenue growth of 0.7% to $717.45 million, beating the consensus of $696.67 million. Domestic…
Deere To Jump Over 33%? These Analysts Boost Price Targets On The Agricultural Equipment Manufacturer Following Q4 Results
Deere & Company (NYSE: DE) reported posted better-than-expected Q4 EPS and sales results.
HC Wainwright & Co. Maintains Buy on Kala Pharmaceuticals, Raises Price Target to $20
HC Wainwright & Co. analyst Yi Chen maintains Kala Pharmaceuticals (NASDAQ:KALA) with a Buy and raises the price target from $12 to $20.